Rashtriya Chemicals and Fertilizers (RCF) Q1 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 24/25 earnings summary
5 Sep, 2025Executive summary
Board approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2024, with a limited review by statutory auditors.
No deviations or variations in the use of proceeds from listed non-convertible debentures; all funds utilized as intended.
New Articles of Association approved, pending ministry and shareholder approval.
Financial highlights
Revenue from operations for Q1 FY25 was ₹4,396.06 crore, up from ₹3,879.65 crore in Q4 FY24 and ₹4,042.95 crore in Q1 FY24.
Net profit after tax for Q1 FY25 stood at ₹10.80 crore, compared to ₹95.24 crore in Q4 FY24 and ₹67.79 crore in Q1 FY24.
EBITDA for Q1 FY25 was ₹145.44 crore, down from ₹223.84 crore in Q4 FY24.
Basic and diluted EPS for Q1 FY25 was ₹0.20, compared to ₹1.73 in Q4 FY24 and ₹1.23 in Q1 FY24.
Total comprehensive income for Q1 FY25 was ₹10.03 crore.
Outlook and guidance
Company recognized estimated compensation of ₹198.32 crore for price adversity in P&K fertilizer imports, as per government directives, with further ₹30.02 crore for unsold inventory and pending sales.
Claims for compensation on prior year imports are pending settlement.
Latest events from Rashtriya Chemicals and Fertilizers
- Q3 FY26 net profit reached ₹80.95 crore, with all NCD proceeds fully utilized and no loan defaults.RCF
Q3 25/2612 Feb 2026 - Strong revenue and profit growth, robust financials, and full compliance on debt utilization.RCF
Q2 25/2614 Nov 2025 - Q2 FY25 saw revenue and profit growth, strong liquidity, and no covenant breaches.RCF
Q2 24/255 Sep 2025 - Q3 FY25 net profit rose to ₹80.23 crore, with all debt covenants and fund use fully compliant.RCF
Q3 24/255 Sep 2025 - Modest profit growth, strong financials, and stable outlook with government support.RCF
Q4 24/255 Sep 2025 - Q1 FY26 profit at ₹54.43 crore, new debentures approved, no debt defaults, JV stake reduced.RCF
Q1 25/265 Sep 2025